Zhengye Biotechnology Holding ZYBT Ratios (2023-2025)

NASDAQ ZYBT
$1.24 -0.06 (-4.58%)
As of: Sep 29, 2026 · 3:50 PM EDT
Reported Financials

Zhengye Biotechnology Holding Quarterly Ratios

Periods 4 quarters
Latest Dec 2025

Zhengye Biotechnology Holding ratios data for the quarter ended Dec 2025. These financial ratios cover 4 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2023 Dec2024 Jun2025 Dec2025
Efficiency
Inventory AverageInventory Avg. 8.10M7.79M6.50M
Assets AverageAssets Avg. 69.05M69.56M65.99M
Equity AverageEquity Avg. 48.10M50.02M47.10M
Invested CapitalInvested Cap. 58.18M61.11M62.33M53.77M
Leverage & Solvency
Debt Ratio 0.160.180.170.17
Valuation
Price to BookP/B 5.351.26
Enterprise Value 275.28M55.20M
Market Capitalization 272.63M54.50M

Zhengye Biotechnology Holding Ratios API

Pull Zhengye Biotechnology Holding's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ZYBT&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY